Drug
P03277 0 1 Mmol KG
P03277 0 1 Mmol KG: highest development phase Phase 1, developed by Guerbet. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Guerbet
Trials
| Drug | Phase | Indication |
|---|---|---|
| P03277 0.1 mmol/kg NCT03657264 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow P03277 0 1 Mmol KG on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.